article

VANTAGE 095: an international, multicenter, open-label study of vorinostat (MK-0683) in combination with bortezomib in patients with relapsed and refractory multiple myeloma

David S Siegel, Meletios Dimopoulos, Sundar Jagannath, Hartmut Goldschmidt, Simon Durrant and 10 more (2016) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Reference details